REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Amorphis Pharma Development Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Other Basic Inorganic Chemical Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Rental and Leasing Services | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Amorphis Pharma Development Sp. z o.o. Profile Updated: March 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Amorphis Pharma Development Sp. z o.o. is based in Poland. The head office is in Katowice. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on November 30, 2018. From the latest financial highlights, Amorphis Pharma Development Sp. z o.o. reported a net sales revenue drop of 79.46% in 2022. Its total assets decreased by 10.09% over the same period. The net profit margin of Amorphis Pharma Development Sp. z o.o. increased by 23.91% in 2022.

Headquarters
Ul. Bankowa 12/147
Katowice; Slaskie; Postal Code: 40-007

Contact Details: Purchase the Amorphis Pharma Development Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Amorphis Pharma Development Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Amorphis Pharma Development Sp. z o.o. report to view the information.
Incorporation Date:
November 30, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
42.74%
Purchase this report to view the information.
15.38%
Purchase this report to view the information.
14.53%
Purchase this report to view the information.
13.68%
Purchase this report to view the information.
13.68%
Company Performance
Financial values in the chart are available after Amorphis Pharma Development Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-79.46%▼
Total operating revenue
-64.64%▼
Operating profit (EBIT)
829.83%▲
EBITDA
-41.81%▼
Net Profit (Loss) for the Period
9965.16%▲
Total assets
-10.09%▼
Total equity
-12.36%▼
Operating Profit Margin (ROS)
22.2%▲
Net Profit Margin
23.91%▲
Return on Equity (ROE)
3.34%▲
Quick Ratio
-0.21%▼
Cash Ratio
-0.16%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo